Neuropsychopharmacology
June 1, 2026
Philip D. Harvey, Charles B. Nemeroff
correction
“Adapted from Mian et al. (2025), with permission.” needs to be added to Fig. 1 caption. Thus, the correct Fig. 1 caption reads: Fig. 1 Thereapeutic Intent, legality and structure. Adapted from Mian et al. (2025), with permission. For instance, a medication that is approved by the FDA for prescription by physicians for a specific condition, manufactured under supervision, and dispensed by a...
Neuropsychopharmacology
January 16, 2026
Philip D. Harvey, Charles B. Nemeroff
2 citations
Interest in psychedelic therapies is booming, with hundreds of studies in process. Despite the interest, there are no approved psychedelic treatments for any psychiatric condition. Further, the one large-scale development program using MDMA that reached the FDA was disapproved by the agency for reasons that could apply to clinical trials for classical psychedelics. We review the definitions of...
Journal of Clinical Psychopharmacology
September 25, 2025
Rachel Landrum, Amanda M. Raines, Philip D. Harvey et al.
1 citation
Maintenance intravenous racemic ketamine therapy demonstrated significant, persistent, and broad efficacy for treatment-resistant depression as demonstrated by reductions in Montgomery-Åsberg Depression Rating Scale and Patient-Health Questionnaire-9 total scores and equivocal changes in every item on both rating scales. The magnitude of change in individual items was similar to that of...
Frontiers in Behavioral Neuroscience
December 23, 2024
Aldrich Chan, Philip D. Harvey, R Hernandez-Cardenache et al.
9 citations
While PTSD continues to be researched in great depth, less attention has been given to the continuum of traumatic responses that resides outside this diagnosis. This investigation begins with a literature review examining the spectrum of responses through the lens of the default mode network (DMN). To build upon this literature, a systematic exploratory study was incorporated, examining...
American Journal of Psychiatry
February 1, 2019
Philip D. Harvey
Societal attitudes toward cannabis use are changing rapidly. In the past decade, there has been awide-ranging movement toward removal of criminal sanctions on cannabis use, and in some localities cannabis use is permitted in a regulated manner, similar to alcohol. This movement has raised some concerns about whether we understand the full implications of cannabis use, particularly in younger...